| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/25/2002 | WO2002057246A2 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057240A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | WO2002057224A2 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
| 07/25/2002 | WO2002050061A8 Piperazine derivatives for treatment of bacterial infections |
| 07/25/2002 | WO2002042268A3 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | WO2002006229A3 Heterocyclic beta-3 adrenergic receptor agonists |
| 07/25/2002 | WO2001068096A3 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | US20020099035 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 07/25/2002 | DE10158803A1 Production of difluoromethoxy-bridged compounds, involves addition of acid to ketene dithioketal, reaction of the carbenium salt with hydroxy compound and fluorodesulfurisation of the dithio-ortho-ester |
| 07/25/2002 | CA2435117A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2434068A1 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2432870A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | CA2425135A1 Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
| 07/24/2002 | EP1225169A1 Radiation-activated cytotoxin therapy |
| 07/24/2002 | EP1224197A1 Hygromycin derivatives |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224182A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223809A1 Methods of treating hair loss comprising administering indoline compound |
| 07/24/2002 | EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1088063C Sulfmidyl (thio) carbonyl-1,2,4-triazolineone deriv. and preparation method and application as weed killer |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423729 Therapeutic or prophylactic agent for glomerulopathy |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423717 Nervous system disorders |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423707 Nitroimidazole ester analogues and therapeutic applications |
| 07/23/2002 | US6423704 Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
| 07/18/2002 | WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | WO2001056974A3 Inha inhibitors and their use as antibacterials |
| 07/18/2002 | US20020094994 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 07/18/2002 | US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/17/2002 | EP1223169A1 Agent for potentiating nerve growth factor activity containg 1,2-ethanediol derivate or salt thereof |
| 07/17/2002 | EP1223166A1 Linked cyclic polyamines with activity against hiv. |
| 07/17/2002 | EP1222308A1 Antiprotozoal histone acetyl transferase inhibitors |
| 07/17/2002 | EP1222305A2 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222176A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| 07/17/2002 | EP1222174A1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1358719A Process for synthesizing sertaconazole |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087736C Novel amidinonaphthyl derivative or salt thereof |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420563 Inverse antagonist |
| 07/16/2002 | US6420541 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/16/2002 | US6420417 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 07/16/2002 | US6420415 Thiol compounds, their production and use |
| 07/16/2002 | US6420412 Eprosartan dihydate and a process for its production and formulation |
| 07/16/2002 | US6420409 Benzimidazole derivatives |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420391 Fused thiophone derivatives and drugs containing the same as the active ingredient |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420375 Fused ring compounds, process for producing the same and use thereof |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/16/2002 | US6420315 5-thien-3-yl-2-oxy- or -2-thio-pyridines; high selectivity for broadleaf and grassy weeds in crops, such as maize and rice; pre- and post-emergence |
| 07/16/2002 | US6420313 Defoliants, desiccants; controlling weeds, such as monocotyledons and dicotyledons in crop fields; pre- and post-emergence; cyclization and alkylation of a biguanide and an alkoxycarbonyl compound |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053155A1 Telomerase inhibitor |
| 07/11/2002 | WO2002028353A3 Phosphate transport inhibitors |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | US20020091274 Taxane derivatives having an amino substituted C13 side chain useful as antileukemia and antitumor agents |
| 07/11/2002 | US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen |
| 07/11/2002 | US20020091150 Carbamic acid derivatives |
| 07/11/2002 | US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors |
| 07/11/2002 | US20020091124 Also used as an antimitotic and for direct and/or indirect inhibition of tubulin polymerization in mammalian |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |